What does this research mean for the field?

Despite a high prevalence of both coagulopathy and diabetic complications among type 2 diabetes mellitus patients, hemostatic abnormalities are not significantly associated with the presence of complications or the level of glycemic control. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the hemostatic profile, its associated risk factors, and its relationship with chronic complications and glycemic control in type 2 diabetes mellitus.

August 23, 2026Journal of Hematology and Allied SciencesOpen Access

Prevalence and relationship of coagulopathy with glycemic control and complications in type 2 diabetes mellitus patients Cameroon

View Full Paper

Ask AI

Bookmark

Authors

SLShey Juliette LabuMinistry of Scientific Research and Innovation EOEbot Walter OjongUniversity of Buea MNMoses Njutain NgemenyaUniversity of Buea

Discussion

Member takes

Implication

Cross-sectional study reveals widespread hemostatic abnormalities in type 2 diabetes regardless of complications or glycemic control, indicating a need for routine coagulation screening.

Key Points

To evaluate the hemostatic profile, its associated risk factors, and its relationship with chronic complications and glycemic control in type 2 diabetes mellitus.
Conducted a cross-sectional analytical study involving 96 type 2 diabetes mellitus patients (73 with complications and 23 without complications) at Laquintinie Hospital in Douala, Cameroon.
Assessed fasting blood glucose, glycated hemoglobin, full blood count, and hemostatic markers, including D-dimer, prothrombin time (PT), activated partial thromboplastin time (APTT), platelets, and fibrinogen.
Coagulopathy was present in 98.96% of participants, with prolonged PT (98.96%), shortened APTT (33.3%), and thrombocytopenia (28.1%) being the most frequent abnormalities.
Diabetic complications were identified in 76.0% of patients—most frequently retinopathy (67.7%) and neuropathy (53.1%)—and were significantly associated with age 64–80 years (p < 0.001) and BMI ≥ 30 kg/m² (p = 0.004).
Hemostatic parameters showed no statistically significant differences between patients with versus without complications, nor between those with good versus poor glycemic control (p > 0.05).

Cite This Study

Labu et al. (2026) studied this question.

synapsesocial.com/papers/6a8aad857677a34114445a8a https://doi.org/10.25259/jhas_65_2025

View Full Paper

Ask AI

Bookmark

Implication

Cross-sectional study reveals widespread hemostatic abnormalities in type 2 diabetes regardless of complications or glycemic control, indicating a need for routine coagulation screening.

Prevalence and relationship of coagulopathy with glycemic control and complications in type 2 diabetes mellitus patients Cameroon

Discussion

Member takes

Implication

Key Points

Cite This Study

Prevalence and relationship of coagulopathy with glycemic control and complications in type 2 diabetes mellitus patients Cameroon

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider